Cryosite Limited (ASX:CTE)
1.220
+0.020 (1.67%)
At close: Oct 26, 2026
Cryosite Market Cap
Cryosite has a market cap or net worth of 59.55 million as of October 27, 2026. It is the 31,437th most valuable company in the world and the 728th biggest in Australia. Its market cap has increased by 10.91% in one year.
Market Cap
59.55M
Enterprise Value
65.02M
Revenue
16.70M
Global Rank
Country Rank
#728 Australia
PE Ratio
28.11
ChartMarket Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 59.55M, an increase of 330,820,272.22%. That is a compound annual growth rate of 84.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 59.55M | 22.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 778.50M |
| Australian Clinical Labs | 542.19M |
| Healius | 315.88M |
| Monash IVF Group | 278.59M |
| Identifai Genetics | 92.15M |
| BCAL Diagnostics | 27.65M |
| Microba Life Sciences | 25.91M |
| Rhythm Biosciences | 24.06M |